DFCI

AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC

Retrieved on: 
Tuesday, March 19, 2024
Research, Genetics, Clinical Trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Oncology, Other Science, CALD, Control, Thyroid cancer, Growth, Bluebird bio, MAA, Drug discovery, Business, MIT, Britz, Patient, SVP, Marketing Authorisation Application, Merck, MSAT, Business development, Acquisition, CMC, Betibeglogene autotemcel, Technology transfer, Senior, MBA, CMCF, Therapy, Takeda, Equinox Group, Dana–Farber Cancer Institute, Multimedia, Chemical engineering, DFCI, Partnership, Biology, BLA, Pharmaceutical industry

AffyImmune Therapeutics, Inc ., a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, affinity-tuned CAR T cell therapies, announced today the appointment of Matt Britz to Chief Executive Officer and Pete Gelinas as Senior Vice President of Chemistry, Manufacturing, and Controls.

Key Points: 
  • AffyImmune Therapeutics, Inc ., a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, affinity-tuned CAR T cell therapies, announced today the appointment of Matt Britz to Chief Executive Officer and Pete Gelinas as Senior Vice President of Chemistry, Manufacturing, and Controls.
  • Matt is well-suited to lead AffyImmune as CEO as the Company accelerates clinical development of AIC100 in thyroid cancer, and in other indications with high unmet medical need.
  • Matt Britz joined AffyImmune in June 2021 as Senior Vice President (SVP), Business Development and was promoted to Chief Operating Officer in January 2022.
  • Pete Gelinas brings over 15 years of extensive experience in Manufacturing and CMC Product Development to AffyImmune.

Dana-Farber Cancer Institute - Merrimack Valley Nurses Vote Overwhelmingly to Ratify First MNA Contract Following Strike Advocating for Investment in Local Nurses and Quality Patient Care

Retrieved on: 
Wednesday, January 24, 2024
DFCI, Dana–Farber Cancer Institute, AOCNP, Commonwealth, Patient, Nursing, Holiday, Life, Multimedia, ATB, Cancer, Workplace, National Nurses United, Practitioner, National Labor Relations Board, Negotiation, Legislature, MNA

METHUEN, Mass., Jan. 24, 2024 /PRNewswire/ -- Registered nurses and nurse practitioners at Dana-Farber Cancer Institute – Merrimack Valley (DFCI – MV), represented by the Massachusetts Nurses Association (MNA), voted on Wednesday, January 24 to ratify a first MNA contract that will help nurses continue to provide the high-quality cancer care that patients in Merrimack Valley need and deserve.

Key Points: 
  • Those two contract areas were critical going into the nurses' one-day strike on September 27 , which was followed by a two-day lockout imposed by DFCI.
  • "Winning this strong MNA contract shows what nurses are capable of when we work together on behalf of our patients and professional practice," said Kate Mitchell, FNP-BC, AOCNP at DFCI – MV.
  • "We are excited to use our contract to help keep nurses at Dana-Farber Merrimack Valley so we can continue to provide high-quality cancer care to local patients."
  • The MNA also represents approximately 600 nurses at the DFCI main campus in Boston under a separate contract.

SABCS23: Reveal Genomics® Unleashes Groundbreaking DNADX® Liquid Biopsy Data for Metastatic Breast Cancer

Retrieved on: 
Monday, December 4, 2023
Biotechnology, Professional Services, Other Health, Health, Oncology, Medical Devices, Research, Surgery, Science, Clinical Trials, Finance, Entrepreneurship, Letrozole, Progression-free survival, Fulvestrant, Plasma, Dana–Farber Cancer Institute, Breast cancer, Patient, Multimedia, PFS, ESR1, Division, Nature Communications, Neoplasm, Blood, Prognosis, MPH, DFCI, Innovation, Breast, Pharmaceutical industry, Medical imaging, MD

REVEAL GENOMICS, S.L., a pioneering biotechnology start-up headquartered in Barcelona committed to advancing cancer care through innovative diagnostic solutions, emphasized the excellent results of DNADX® in data presented at the San Antonio Breast Cancer Symposium 2023 (SABCS23).

Key Points: 
  • REVEAL GENOMICS, S.L., a pioneering biotechnology start-up headquartered in Barcelona committed to advancing cancer care through innovative diagnostic solutions, emphasized the excellent results of DNADX® in data presented at the San Antonio Breast Cancer Symposium 2023 (SABCS23).
  • View the full release here: https://www.businesswire.com/news/home/20231204265236/en/
    The RELIEVE study, conducted by the Dana-Farber Cancer Institute (DFCI), analyzed plasma samples from patients with HER2+ and HER2- metastatic breast cancer receiving T-DXd monotherapy.
  • DNADX® subtypes, evaluated across 80 pre-treatment plasma samples, exhibited significant associations with time-to-next-treatment (TTNT) and overall survival (OS).
  • This endorsement not only signifies the recognition of DNADX® as an innovative tool, but also underscores its clinical utility.”

MNA: Dana-Farber Merrimack Valley Nurses to Leaflet Outside Boston Hospital September 29 about DFCI Spending Money on Lock Out After Strike Instead of Investing in Nurses and Cancer Patients

Retrieved on: 
Thursday, September 28, 2023
National Nurses United, State, AOCNP, Legislature, Dana–Farber Cancer Institute, Nursing, DFCI, Workplace, D. Lawrence Kincaid, Brigham and Women's Hospital, Cancer, Multimedia, Movement, Patient, Practitioner, Hospital, Commonwealth, Merrimack, Disease, MNA, Merrimack Valley

BOSTON, Sept. 28, 2023 /PRNewswire/ -- During a lockout inflicted on Merrimack Valley nurses and patients by Dana-Farber Cancer Institute (DFCI) following a one-day strike, nurses will meet outside the DFCI hospital in Boston on Friday, September 29 to leaflet the public and share their concerns about how Dana-Farber executives are spending critical resources.

Key Points: 
  • DFCI – MV nurses and nurse practitioners held a one-day strike on September 27 because DFCI executives refused to make reasonable compromises with nurses to reach a fair contract.
  • Instead of reaching a reasonable compromise with nurses, DFCI is refusing to let nurses back to work following the strike.
  • DFCI executives are spending money on travelers rather than allowing local nurses to care for their patients.
  • DFCI is disaffiliating from Brigham and Women's Hospital and spending millions on a new inpatient hospital.

MNA: Nurses Prepare to Strike at Dana-Farber Cancer Institute - Merrimack Valley on September 27 as DFCI Executives Refuse to Meet RN Needs and Threaten Lockout Using Travelers

Retrieved on: 
Tuesday, September 26, 2023
Workforce, Exercise, National Nurses United, State, AOCNP, Legislature, Beth Israel Deaconess Medical Center, Dana–Farber Cancer Institute, Nursing, DFCI, Strike, D. Lawrence Kincaid, Workplace, Brigham and Women's Hospital, Cancer, Multimedia, Movement, Investment, Practitioner, Patient, Hospital, Commonwealth, Health, Disease, MNA, Isaac Branch (St. Jones River tributary), Merrimack Valley

METHUEN, Mass., Sept. 26, 2023 /PRNewswire/ -- A one-day strike by Dana-Farber Cancer Institute (DFCI) – Merrimack Valley registered nurses and nurse practitioners appears likely to begin at 6:30 a.m. on Wednesday, September 27 because DFCI executives have refused to make reasonable compromises with nurses to reach a fair contract.

Key Points: 
  • Instead, DFCI executives have threatened to lock out nurses after the strike and spend precious patient care resources on travelers.
  • DFCI – MV nurses are seeking to secure existing benefits and receive competitive pay, which would enable them to provide the high-quality cancer care Merrimack Valley patients deserve.
  • DFCI has made minimal movement since nurses announced their strike, including no agreement on benefits and daily overtime standards.
  • "We are prepared to strike if necessary to protect cancer care quality and access for Merrimack Valley patients," said Kerrin Albert, Infusion RN at DFCI – MV.

Dana-Farber Cancer Institute Makes no Substantial Movement Ahead of One-Day Strike by MNA Nurses at Merrimack Valley Clinic; DFCI Threatens to Lock Out Nurses Using Travelers

Retrieved on: 
Tuesday, September 19, 2023
Workforce, Exercise, National Nurses United, State, AOCNP, Employment, Beth Israel Deaconess Medical Center, National Labor Relations Board, Dana–Farber Cancer Institute, DFCI, Strike, R. D. Lawrence, Brigham and Women's Hospital, Cancer, Nursing, Movement, Retirement, Investment, Patient, MV, Hospital, Health, Disease, MNA, Merrimack Valley

METHUEN, Mass., Sept. 19, 2023 /PRNewswire/ -- Dana-Farber Cancer Institute (DFCI) refused to make meaningful progress on key Merrimack Valley nurse issues during negotiations on September 19, and threatened to lock out nurses for two days following their planned one-day strike on September 27.

Key Points: 
  • Nurses were required by labor law to give DFCI at least 10 days' notice before the strike.
  • "We are prepared to strike if necessary to protect cancer care quality and access for Merrimack Valley patients," said Kerrin Albert, Infusion RN at DFCI – MV.
  • DFCI – MV nurses held an informational picket on June 2 attended by nurses, community members, union supporters, and elected officials.
  • MV nurses have proposed wages that are less than what DFCI Boston nurses earn, and DFCI has still said no.

One-Day Strike Notice Issued by MNA Nurses at Dana-Farber Cancer Institute - Merrimack Valley After DFCI Refuses to Agree to a Contract with Competitive Pay and Benefits Security

Retrieved on: 
Saturday, September 16, 2023
Workforce, Exercise, National Nurses United, State, AOCNP, Employment, Beth Israel Deaconess Medical Center, National Labor Relations Board, Dana–Farber Cancer Institute, DFCI, Strike, J. D. Lawrence (playwright), Brigham and Women's Hospital, Cancer, Nursing, Retirement, Investment, Patient, MV, Hospital, Disease, MNA, Merrimack Valley

METHUEN, Mass., Sept. 16, 2023 /PRNewswire/ --The registered nurses of Dana-Farber Cancer Institute – Merrimack Valley, represented by the Massachusetts Nurses Association, issued notice to DFCI on Friday evening that they plan to hold a one-day strike on Wednesday, September 27 unless the institute agrees to a fair contract that provides secured benefits and competitive pay, enabling nurses to provide the high-quality cancer care Merrimack Valley patients deserve.

Key Points: 
  • Nurses were required by labor law to give DFCI at least 10 days' notice before the strike.
  • This plan will cost many millions of dollars, while DFCI refuses to make reasonable investments in its existing nurse and nurse practitioner workforce in Merrimack Valley.
  • "We are prepared to strike if necessary to protect cancer care quality and access for Merrimack Valley patients," said Kerrin Albert, Infusion RN at DFCI – MV.
  • MV nurses have proposed wages that are less than what DFCI Boston nurses earn, and DFCI has still said no.

MNA Nurses at Dana-Farber Cancer Institute - Merrimack Valley Vote to Authorize One-Day Strike as DFCI Refuses to Treat Nurses Equally and Settle a Fair Contract

Retrieved on: 
Wednesday, August 2, 2023
Workforce, National Nurses United, State, AOCNP, Employment, National Labor Relations Board, Dana–Farber Cancer Institute, DFCI, J. D. Lawrence (playwright), Cancer, Nursing, Retirement, Patient, Risk, MV, Health, Disease, MNA, Merrimack Valley

METHUEN, Mass., Aug. 2, 2023 /PRNewswire/ -- The registered nurses of Dana-Farber Cancer Institute – Merrimack Valley, represented by the Massachusetts Nurses Association, voted on Wednesday, August 2 to authorize a one-day strike because Dana-Farber executives have refused to agree to a fair contract that would provide equal benefits and competitive pay, and enable nurses to provide the high-quality cancer care Merrimack Valley patients deserve.

Key Points: 
  • The vote gives the nurses elected to the DFCI – MV MNA Bargaining Committee authorization to hold a one-day strike if necessary.
  • DFCI – MV nurses would then plan to hold a 24-hour strike unless DFCI agreed to a fair contract by that date.
  • Through the mediator on July 13, DFCI told Merrimack Valley nurses that they were not entitled to the same benefits as Boston-based DFCI nurses.
  • DFCI must settle a fair contract with MV nurses to demonstrate its commitment to local patients.

L7 Informatics Supports Cancer Research at Dana Farber Cancer Institute

Retrieved on: 
Tuesday, June 13, 2023
GXP, DFCI, Computer, Cancer, Research, Haematopoietic system, CMCF, Connell, Organization, Patient, Informatics, Medicine, Quality control, Health, Safety, Dana–Farber Cancer Institute, Medical device

AUSTIN, Texas, June 13, 2023 /PRNewswire/ -- L7 Informatics, provider of the leading unified platform for integrated data and workflow solutions for the life sciences industry, announces the implementation of their flagship product, L7|ESP software, at the Connell and O'Reilly Families Cell Manipulation Core Facility (CMCF) of the prestigious Dana-Farber Cancer Institute (DFCI). Dr. Jerome Ritz, a renowned cancer research pioneer and Executive Director of CMCF, spearheaded the adoption of L7|ESP to enhance the manufacturing of cellular therapy products and improve patient outcomes.

Key Points: 
  • Dr. Jerome Ritz, a renowned cancer research pioneer and Executive Director of CMCF, spearheaded the adoption of L7|ESP to enhance the manufacturing of cellular therapy products and improve patient outcomes.
  • As an expert in cellular therapy and a pioneer in stem cell transplantation, Dr. Ritz leads the CMCF team that manufactures innovative cell-based therapies for cancer patients enrolled in novel therapeutic clinical research protocols.
  • Additionally, Dr. Ritz's laboratory supports clinical research studies aimed at evaluating the safety and efficacy of these groundbreaking treatments.
  • L7 Informatics remains committed to advancing precision medicine and transforming the healthcare industry through its innovative solutions.

MNA Nurses at Dana-Farber Cancer Institute - Merrimack Valley to Hold an Informational Picket Friday, June 2 as They Seek a Fair Contract to Help Them Provide High-Quality Patient Care

Retrieved on: 
Tuesday, May 30, 2023
National Nurses United, AOCNP, Legislature, Dana–Farber Cancer Institute, Nursing, DFCI, Workplace, COVID-19, Cancer, Human, Multimedia, Retirement, Work, Patient, Commonwealth, Health, MNA, Hospital, Isaac Branch (St. Jones River tributary)

METHUEN, Mass., May 30, 2023 /PRNewswire/ -- The registered nurses of Dana-Farber Cancer Institute – Merrimack Valley, represented by the Massachusetts Nurses Association, will hold an informational picket on Friday, June 2 after calling in a federal mediator to help resolve negotiations in which DFCI refuses to help ensure high-quality patient care by agreeing to a fair nurse contract.

Key Points: 
  • Location: Outside Dana-Farber Cancer Institute – Merrimack Valley at 5 Branch St., Methuen, MA.
  • Nurses are seeking fair pay and equal benefits as DFCI Boston nurses, allowing DFCI – MV to maintain the nurses necessary to provide critical patient care.
  • "A fair nurse contract will give us a stronger voice in ensuring safe patient care conditions and the pay and benefits we need to retain the highly qualified nurses DFCI – MV needs."
  • Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts.